Assignee
CANTAB BIOPHARMACEUTICALS PATENTS LTD
MT·2 granted patents·8 pending applications·0 citations·filing 2013–2024
Top patents by PatentIndex Score
10 records- 0167US2025170244A1Colloidal particles for use in medicineCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2024·Application pending·0 cites
- 0260US11484499B2Pharmaceutical formulations of PEGylated liposomes and blood coagulation factorsCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2018·Granted Nov 1, 2022·0 cites·13 claims
- 0350US2021093721A1Colloidal particles for use in medicineCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2020·Application pending·0 cites
- 0449US11351112B2Optimised subcutaneous therapeutic agentsCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2017·Granted Jun 7, 2022·0 cites·5 claims
- 0547US2025064738A1Modified colloidal particles for use in the treatment of haemophilia aCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2022·Application pending·0 cites
- 0639US2024366732A1Modified colloidal particles for use in the treatment of haemophilia aCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2022·Application pending·0 cites
- 0739US2024358801A1Modified colloidal particles for use in the treatment of haemophilia aCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2022·Application pending·0 cites
- 0837US2017304203A1Pharmaceutical Formulations of PEGylated Liposomes and Blood Coagulation FactorsCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2015·Application pending·0 cites
- 0937US2015086524A1Optimised subcutaneous therapeutic agentsCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2013·Application pending·0 cites
- 1037US2019192664A1Colloidal particles for use in medicineCANTAB BIOPHARMACEUTICALS PATENTS LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CANTAB BIOPHARMACEUTICALS PATENTS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →